BELLEVUE, Wash. — BioControl Systems has completed the acquisition of Raisio Diagnostics, a Finland-based manufacturer and supplier of industrial diagnostic tests used in food and beverage processing, commercial testing laboratories and government applications.
The acquisition allows BioControl to provide its global customer base with a range of validated, rapid detection methods across multiple technology formats.
“Raisio Diagnostics has established a portfolio of highly regarded rapid methods which complement BioControl’s existing line of detection systems,” said Phil Feldsine, CEO of BioControl Systems, in a release. “Raisio’s line of rapid methods will allow us to enhance our product offering to existing customers as well as grow our presence in new markets.”
Raisio Diagnostics’ portfolio of detection methods includes:
- The Transia line of lateral flow and ELISA-format detection systems for a range of pathogens including Salmonella, Listeria spp., Listeria monocytogenes and Staphylococcal enterotoxin.
- The EC and Enzyplus lines of enzymatic tests for quality control testing, primarily in the beverage industry
- Magda CA, a microfluidic chip-based solution for DNA analysis